Showing results (811-820 of 31,337) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|August 4, 2006
Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrateTakayoshi Suzuki, Akiyasu Kouketsu, Yukihiro Itoh, et al.Journal of Medicinal Chemistry|August 4, 2006
Chromatographic estimation of drug disposition properties by means of immobilized artificial membranes (IAM) and C18 columnsElisabet Lázaro, Clara Ràfols, Michael H Abraham, et al.Journal of Medicinal Chemistry|August 4, 2006
Synthesis and antifungal activity of a novel series of alkyldimethylamine cyanoboranes and their derivativesKhuloud Takrouri, Gal Oren, Itzhack Polacheck, et al.Journal of Medicinal Chemistry|August 4, 2006
Structural determinants for the membrane interaction of novel bioactive undecapeptides derived from gaegurin 5Hyung-Sik Won, Min-Duk Seo, Seo-Jeong Jung, et al.Journal of Medicinal Chemistry|August 4, 2006
In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probesSimonetta Geninatti Crich, Claudia Cabella, Alessandro Barge, et al.Journal of Medicinal Chemistry|August 4, 2006
Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activityMatthew W Martin, John Newcomb, Joseph J Nunes, et al.Journal of Medicinal Chemistry|August 4, 2006
Probing hot spots at protein-ligand binding sites: a fragment-based approach using biophysical methodsAlessio Ciulli, Glyn Williams, Alison G Smith, et al.Journal of Medicinal Chemistry|May 8, 2007
Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)David R Anderson, Marvin J Meyers, William F Vernier, et al.Journal of Medicinal Chemistry|June 9, 2007
Synthesis, biochemical, and cellular evaluation of farnesyl monophosphate prodrugs as farnesyltransferase inhibitorsMichelle K Clark, Sarah A Scott, Jonathan Wojtkowiak, et al.Journal of Medicinal Chemistry|June 15, 2007
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosisAldo Andreani, Silvia Burnelli, Massimiliano Granaiola, et al.Pageof 3,134